{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:37:11Z","timestamp":1775219831422,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29802-9","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:54:31Z","timestamp":1766055271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of netrin 1 as a new biomarker in the differentiation of psoriatic arthritis from psoriasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Ahmet","family":"Kor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Erduran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar Can","family":"G\u00fcven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Ecem","family":"Konak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015e\u00fckran","family":"Erten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"29802_CR1","doi-asserted-by":"crossref","unstructured":"Scotti, L., Franchi, M., Marchesoni, A. & Corrao, G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Paper presented at the Seminars in Arthritis and Rheumatism. Vol. 48 pp. 28\u201334, Elsevier (2018).","DOI":"10.1016\/j.semarthrit.2018.01.003"},{"key":"29802_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease, P. J. et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J. Am. Acad. Dermatol. 69, 729\u2013735 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"29802_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11926-012-0263-5","volume":"14","author":"WJ Taylor","year":"2012","unstructured":"Taylor, W. J. Impact of psoriatic arthritis on the patient: through the lens of the WHO international classification of functioning. Health Disabil. Curr. Rheumatol. Rep. 14, 369\u2013374 (2012).","journal-title":"Health Disabil. Curr. Rheumatol. Rep."},{"key":"29802_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N. Engl. J. Med. 376, 957\u2013970 (2017).","journal-title":"N. Engl. J. Med."},{"key":"29802_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson, F. C. et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study. Arthritis Care Res. 61, 233\u2013239 (2009).","journal-title":"Arthritis Care Res."},{"key":"29802_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/09546630902817887","volume":"20","author":"SL Taylor","year":"2009","unstructured":"Taylor, S. L., Petrie, M., O\u2019Rourke, K. S. & Feldman, S. R. Rheumatologists\u2019 recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients\u2019 joint symptoms. J. Dermatol. Treat. 20, 350\u2013353 (2009).","journal-title":"J. Dermatol. Treat."},{"issue":"573","key":"29802_CR7","first-page":"e1","volume":"53","author":"JM Gelfand","year":"2005","unstructured":"Gelfand, J. M. et al. Epidemiology of psoriatic arthritis in the population of the United States. J. Am. Acad. Dermatol. 53(573), e1-57313.e13 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"29802_CR8","doi-asserted-by":"publisher","first-page":"1054539","DOI":"10.3389\/fimmu.2022.1054539","volume":"13","author":"T Wirth","year":"2022","unstructured":"Wirth, T., Balandraud, N., Boyer, L., Lafforgue, P. & Pham, T. Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. Front. Immunol. 13, 1054539 (2022).","journal-title":"Front. Immunol."},{"key":"29802_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.23298","volume":"70","author":"D Cretu","year":"2018","unstructured":"Cretu, D. et al. Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers. Arthritis Care Res. 70, 454\u2013461 (2018).","journal-title":"Arthritis Care Res."},{"key":"29802_CR10","doi-asserted-by":"publisher","first-page":"14729","DOI":"10.1073\/pnas.0506233102","volume":"102","author":"NP Ly","year":"2005","unstructured":"Ly, N. P. et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc. Natl. Acad. Sci. 102, 14729\u201314734 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"29802_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1164\/rccm.200905-0717OC","volume":"181","author":"V Mirakaj","year":"2010","unstructured":"Mirakaj, V. et al. Netrin-1 dampens pulmonary inflammation during acute lung injury. Am. J. Respir. Crit. Care Med. 181, 815\u2013824 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"29802_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.1683","volume":"10","author":"P Rosenberger","year":"2009","unstructured":"Rosenberger, P. et al. Hypoxia-inducible factor\u2013dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195\u2013202 (2009).","journal-title":"Nat. Immunol."},{"key":"29802_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4161\/cc.9.8.11197","volume":"9","author":"M Castets","year":"2010","unstructured":"Castets, M. & Mehlen, P. Netrin-1 role in angiogenesis: to be or not to be a pro-angiogenic factor?. Cell Cycle 9, 1466\u20131471 (2010).","journal-title":"Cell Cycle"},{"key":"29802_CR14","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-12-1463","volume":"72","author":"Y Yang","year":"2012","unstructured":"Yang, Y., Wang, X., Moore, D. R., Lightfoot, S. A. & Huycke, M. M. TNF-\u03b1 mediates macrophage-induced bystander effects through netrin-1. Can. Res. 72, 5219\u20135229 (2012).","journal-title":"Can. Res."},{"key":"29802_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2019.00124","volume":"11","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. Decreased Netrin-1 and correlated Th17\/Tregs balance disorder in A\u03b21\u201342 induced Alzheimer\u2019s disease model rats. Front. Aging Neurosci. 11, 124 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"29802_CR16","doi-asserted-by":"publisher","first-page":"11662","DOI":"10.3390\/ijms241411662","volume":"24","author":"B-W Lee","year":"2023","unstructured":"Lee, B.-W. & Moon, S.-J. Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment. Int. J. Mol. Sci. 24, 11662 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29802_CR17","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.jid.2024.10.608","volume":"145","author":"X Tong","year":"2024","unstructured":"Tong, X. et al. Crosstalk in skin: Loss of desmoglein 1 in keratinocytes inhibits BRAFV600E-induced cellular senescence in human melanocytes. J. Investig. Dermatol. 145, 1740-1752.e4 (2024).","journal-title":"J. Investig. Dermatol."},{"key":"29802_CR18","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1111\/jcmm.17950","volume":"27","author":"Z Ma","year":"2023","unstructured":"Ma, Z. et al. Activation of vascular endothelial cells by synovial fibrosis promotes Netrin-1-induced sensory nerve sprouting and exacerbates pain sensitivity. J. Cell Mol. Med. 27, 3773\u20133785 (2023).","journal-title":"J. Cell Mol. Med."},{"key":"29802_CR19","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1096\/fj.201600615R","volume":"30","author":"A Mediero","year":"2016","unstructured":"Mediero, A., Wilder, T., Ramkhelawon, B., Moore, K. J. & Cronstein, B. N. Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis. FASEB J. 30, 3835 (2016).","journal-title":"FASEB J."},{"key":"29802_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/039463200902200317","volume":"22","author":"T Schubert","year":"2009","unstructured":"Schubert, T. et al. Role of the netrin system of repellent factors on synovial fibroblasts in rheumatoid arthritis and osteoarthritis. Int. J. Immunopathol. Pharmacol. 22, 715\u2013722 (2009).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"29802_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2024.110760","volume":"127","author":"A Kor","year":"2024","unstructured":"Kor, A. et al. Serum netrin-1 levels are high in Rheumatoid arthritis associated interstitial lung disease. Clin. Biochem. 127, 110760 (2024).","journal-title":"Clin. Biochem."},{"key":"29802_CR22","first-page":"1202","volume":"39","author":"E Atalar","year":"2022","unstructured":"Atalar, E., G\u00f6k, K., O\u011fuz, E. F., Kor, A. & Mara\u015f, Y. Plasma netrin-1 levels in Familial Mediterranean fever: A potential biomarker?. Deneysel ve Klinik T\u0131p Dergisi. 39, 1202\u20131206 (2022).","journal-title":"Deneysel ve Klinik T\u0131p Dergisi."},{"key":"29802_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejr.2022.10.003","volume":"45","author":"Y Mara\u015f","year":"2023","unstructured":"Mara\u015f, Y. et al. Serum netrin-1 levels in systemic sclerosis patients with capillary abnormalities. Egypt. Rheumatol. 45, 51\u201354 (2023).","journal-title":"Egypt. Rheumatol."},{"key":"29802_CR24","first-page":"44","volume":"16","author":"G \u00d6zan","year":"2024","unstructured":"\u00d6zan, G. et al. Evaluation of the relationship between serum netrin-1 level and patient characteristics in rheumatoid arthritis Romatoid artritte serum netrin-1 d\u00fczeyi ile hasta \u00f6zellikleri aras\u0131ndaki ili\u015fkinin de\u011ferlendirilmesi. J. Turk. Soc. Rheumatol. 16, 44\u201355 (2024).","journal-title":"J. Turk. Soc. Rheumatol."},{"key":"29802_CR25","volume":"127","author":"A Kor","year":"2023","unstructured":"Kor, A. et al. Evaluation of the relationship between lymphoma predictors, disease activity, and netrin-1 in primary Sj\u00f6gren\u2019s syndrome. J. Turk. Soc. Rheumatol. 127, 110760 (2023).","journal-title":"J. Turk. Soc. Rheumatol."},{"key":"29802_CR26","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 54, 2665\u20132673 (2006).","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"29802_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000083509","volume":"210","author":"J Schmitt","year":"2005","unstructured":"Schmitt, J. & Wozel, G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210, 194\u2013199 (2005).","journal-title":"Dermatology"},{"key":"29802_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.berh.2014.10.004","volume":"28","author":"PM Machado","year":"2014","unstructured":"Machado, P. M. & Raychaudhuri, S. P. Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 28, 711\u2013728 (2014).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"29802_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14397595.2020.1812870","volume":"31","author":"K Nas","year":"2021","unstructured":"Nas, K. et al. The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod. Rheumatol. 31, 869\u2013874 (2021).","journal-title":"Mod. Rheumatol."},{"key":"29802_CR30","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.2174\/0109298673295359240422115759","volume":"31","author":"A Kor","year":"2024","unstructured":"Kor, A. et al. Does Eta protein differentiate rheumatoid arthritis from psoriatic arthritis?. Curr. Med. Chem. 31, 6510\u20136520 (2024).","journal-title":"Curr. Med. Chem."},{"key":"29802_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/ijms23010275","volume":"23","author":"L Ziegon","year":"2021","unstructured":"Ziegon, L. & Schlegel, M. Netrin-1: A modulator of macrophage driven acute and chronic inflammation. Int. J. Mol. Sci. 23, 275 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"29802_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/biom15070921","volume":"15","author":"Y Wu","year":"2025","unstructured":"Wu, Y., Liu, Z., Xu, P., Yin, K. & Wang, S. The role of macrophage-derived netrin-1 in inflammatory diseases. Biomolecules 15, 921 (2025).","journal-title":"Biomolecules"},{"key":"29802_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/life12010111","volume":"12","author":"D Romh\u00e1nyi","year":"2022","unstructured":"Romh\u00e1nyi, D., Szab\u00f3, K., Kem\u00e9ny, L., Sebesty\u00e9n, E. & Groma, G. Transcriptional analysis-based alterations affecting neuritogenesis of the peripheral nervous system in psoriasis. Life. 12, 111 (2022).","journal-title":"Life."},{"key":"29802_CR34","doi-asserted-by":"publisher","first-page":"15286","DOI":"10.3390\/ijms232315286","volume":"23","author":"Q Yue","year":"2022","unstructured":"Yue, Q. et al. Identification of novel hub genes associated with psoriasis using integrated bioinformatics analysis. Int. J. Mol. Sci. 23, 15286 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"29802_CR35","doi-asserted-by":"crossref","unstructured":"Alahmed, A. & Al-Rubaee, E. New insight for ulcerative colitis diagnosis via serum netrin-1 and galectin-1 biomarkers, Human Antibodies. 10932607251349069 (2025).","DOI":"10.1177\/10932607251349069"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29802-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:41:38Z","timestamp":1767624098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29802-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29802"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29802-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the 1st Ethics Committee of Ankara Bilkent City Hospital, dated August 16, 2023, and numbered E1-23-3892. All patients were included in the study after providing informed consent beforehand. All stages of this study were conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice, as well as the country\u2019s legal operating procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"400"}}